Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV003283411 | SCV004002683 | uncertain significance | Cardiovascular phenotype | 2023-03-29 | criteria provided, single submitter | clinical testing | The p.N423K variant (also known as c.1269C>A), located in coding exon 10 of the SOS1 gene, results from a C to A substitution at nucleotide position 1269. The asparagine at codon 423 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |